Juno Therapeutics has been in the news lately; they "went public" on the NASDAQ exchange recently (you can look up the stock with the symbol JUNO). Juno was also featured in Seattle Business magazine last month, in a fascinating article about the business climate for biotechnology here in Seattle. The article explores how Juno fits into that picture, and is well worth the time it takes to read; you can access it easily by clicking the link HERE.
The day we have prayed for is drawing closer through this research - the day when we stop poisoning cancer patients with chemotherapy and radiation, and strengthen their bodies using their own immune system's T-cells. Katie would be thrilled - somehow, I believe that she IS thrilled.
Showing posts with label cancer. Show all posts
Showing posts with label cancer. Show all posts
Tuesday, January 20, 2015
Monday, August 11, 2014
2014 Financial Report
- Market Value on 3/31/2013: $192,743
- Contributions between 4/1/13 and 3/31/14: $27,820
- Market Value as of 3/31/14: $238,316
- Distributions to Program (to the Jensen Lab at the Ben Towne Center for Childhood Cancer Research): $8,496
This research has already saved the lives of two cancer patients who had no other treatment options. The research will continue and expand to other types of cancers because of the continuing distributions generated by the principal of this endowment (combined with other sources). Your gifts are giving hope, care and cure to patients and their families - and saving lives.
These breakthroughs in curing cancer come just seven years after Katie's passing, and they are a beautiful legacy for her.
Thank you for helping to create that legacy!
Tuesday, February 18, 2014
Another Patient in Remission!
Seattle Children's Hospital's Ben Towne Center for Childhood Cancer Research has announced that the second patient in the (PLAT)-01 clinical trial of therapy for relapsed leukemia at the is in remission! This is the work which the Katie Gerstenberger Endowment (and the Ben Towne Foundation) supports. Both Dr. Gardner and Dr. Park treated Katie when she was in the hospital, and she would be thrilled with their success, and the good work which her endowment is supporting and moving forward.
You can read all about it here:
From hopeless to cancer free
You can read all about it here:
From hopeless to cancer free
Wednesday, January 15, 2014
Phase II Clinical Trial Approved & JUNO THERAPEUTICS
Ben Towne Center for Childhood Cancer Research Profile from ben towne foundation on Vimeo.
Just before Christmas, we received this good news from the Ben Towne Center for Childhood Cancer Research's Jensen Lab (which the Katie Gerstenberger Endowment supports):
“The FDA’s authorization of our second pediatric leukemia T cell therapy protocol is a milestone for the Ben Towne Center for Childhood Cancer Research. This trial will allow us to treat patients age 12 months-27 years of age who are in the worst possible situation—relapse after bone marrow transplantation. We will be able to enroll and treat patients on an accelerated time table with our latest version of the reprogrammed T cell product that was developed in our laboratories here at BTCCCR with the help of our generous donors. One exciting element of this trial called PLAT-02 is that it is a combined Phase I trial to establish safety that then rolls in to a larger Phase II trial to establish efficacy."We know for many children that we treat, this will be their last chance to beat their leukemia.” - Michael C. Jensen, MD
Dr. Rebecca Gardner (who speaks in the video above) was one of Katie's doctors.
And there is more good news: the formation of "a new biotechnology company focused on bringing forward novel immunotherapies for cancer," called Juno Therapeutics. This is a joint venture of Seattle Children's Research Institute (of which the BTCCCR is part), Fred Hutchinson Cancer Research Center and Memorial Sloan-Kettering. You can visit their website to learn more: junotherapeutics.com
| Dr. Pollard on the left, Katie and Dr. Gardner on the right, December 2006 |
The site contains press releases with fabulous news of over $145 million in venture capital committed to supporting this research. You can access the press releases here:
- Leading Cancer Research Centers Team Up to Launch Biotech Startup Focused on Cancer Immunotherapy
- Juno Announces New Investments, Leadership Appointments
Two scientists who we know personally (and admire deeply), Kendall Mohler, Ph.D. and Dr. Michael Jensen, are key members of the Juno team. I am thrilled to know that the torch is being carried by such compassionate, brilliant, talented, accomplished scientists.
The potential of this venture is unlimited. It is what I dreamed might be possible in the first dark months after Katie's passing. To see it happening, right here in Seattle, is truly a dream-come-true, and an answer to prayers.
Thursday, October 10, 2013
More Good News
![]() |
| 1100 people gathered for the Ben Towne Foundation's BENefit 2013 (Image: Bryce Covey Photography) |
Around
here, autumn is the time when many charities host fundraisers. Gregg
and I are always pleased to attend the Ben Towne Foundation's annual
BENefit. We've had the privilege of being an active part of this event
from its inception, and watching it grow each year lifts my heart like
no other "gala" can.
![]() |
| Jeff & Carin Towne with Dr. Michael Jensen (Image: Bryce Covey Photography) |
![]() |
| Reba & Mary-Jane with me |
The news is good, my friends: the first patient in the clinical trial of T-Cell therapy continues to enjoy remission, gained after only 9 days of treatment, with side effects of flu-like symptoms during that time. Her mother was a guest at the BENefit, and spoke to the audience about what our support for this therapy means to her. The next patient is ready to enroll, and it looks as if the clinical trial will soon be expanded to include a much broader range of ages - open for more patients to be treated and cured in this new, non-toxic way!
Did you know that it can cost 10 times more to treat a child with traditional chemotherapy than with T-Cell therapy - and surgery costs even more? The bill for Katie's care was in the neighborhood of a million dollars, for which we were (thank God) covered by medical insurance - but there are many whose finances are completely wiped out by such treatment, and without the promise of a cure!
Think of it this way: you could spend $350,000 for a patient to endure chemo, which can cause secondary cancers, organ damage, susceptibility to infections and reproductive problems - or $30,000 for a patient to have T-Cell therapy, with no long-term damage whatsoever, and continuing immune-system support for remission. Which would you choose for your child - or for yourself? What would you like to see become the "norm?"
On this day - the very one on which Katie was admitted into the hospital in 2006 - people such as Katie, Carin and Jeff Towne, Dr. Jensen and Dr. Gardner inspire me. Who (or what) inspires you to give?
Tuesday, November 9, 2010
Seattle Children's Cancer Advocacy Network (C.A.N.)

Wednesday, September 15, 2010
THANKS and HOPE
Our generous family and friends, we
thank you.
The principal balance of the
Katie Gerstenberger
Endowment for Cancer Research
as of August, 2010 is
$121,209.
Dr. Jensen is pioneering the use of the body's own immune system to treat cancer. He has succeeded in "teaching" immune system cells to recognize cancer cells, and to destroy them. You can see and hear Dr. Jensen explaining how it works in
Please take a few moments to watch, and be filled with HOPE.
It is happening - our hopes, our prayers, are on the way to being answered. Thanks be to God!
Labels:
cancer,
endowment,
hope,
research,
Seattle Children's Hospital
Wednesday, July 14, 2010
Thursday, June 24, 2010
The Seattle Children's Cancer Advocacy Network (CAN)
There is a new blog on the block! The Seattle Children's Cancer Advocacy Network (CAN) is a group that is meeting monthly to prepare for September's Childhood Cancer Awareness Month, and it now has a blog: http://www.seattlechildrenscan.blogspot.com/ . Please visit (and follow) to learn what is going on with the guilds that support cancer research. Everyone is welcome!
Katie's Comforters Guild is listed as one of the guilds that supports cancer research. The guild's connection to cancer research is 1) because Katie died of cancer, 2) our family and friends created the Katie Gerstenberger Endowment for Cancer Research in 2007 and 3) we began our work by sewing quilts for children in the cancer ward at Seattle Children's Hospital - and we've now expanded to blanket the entire hospital. As you know, Katie's endowment is for solid tumor research, to help find a cure for the kind of tumor she had (adrenocortical carcinoma). Since adrenocortical carcinoma is very rare, Katie's endowment supports ALL solid tumor research with the income that is generated by the principal in the endowment. At last count, the principal was just over $100,000.
We are thankful for the creation of the Seattle Children's Cancer Advocacy Network (CAN), and excited to see what lies ahead.
Katie's Comforters Guild is listed as one of the guilds that supports cancer research. The guild's connection to cancer research is 1) because Katie died of cancer, 2) our family and friends created the Katie Gerstenberger Endowment for Cancer Research in 2007 and 3) we began our work by sewing quilts for children in the cancer ward at Seattle Children's Hospital - and we've now expanded to blanket the entire hospital. As you know, Katie's endowment is for solid tumor research, to help find a cure for the kind of tumor she had (adrenocortical carcinoma). Since adrenocortical carcinoma is very rare, Katie's endowment supports ALL solid tumor research with the income that is generated by the principal in the endowment. At last count, the principal was just over $100,000.
We are thankful for the creation of the Seattle Children's Cancer Advocacy Network (CAN), and excited to see what lies ahead.
Wednesday, June 17, 2009
The Katie Gerstenberger Endowment at Seattle Children's Hospital
Dear Friends,This blog was created to keep you up to date on what is going on over at the Katie Gerstenberger Endowment for Cancer Research (solid tumors) at Seattle Children's Hospital.
Katie was a vibrant, active, intelligent, kind, funny sparkly girl of 11 when she was diagnosed with a huge tumor in her abdomen. She had no symptoms until about 3 weeks before her diagnosis, when she began to exhibit the symptoms of a virus. After 3 weeks of clinic visits and tests, the horrendous news came that she was in grave danger of losing her life, and had to be admitted to the hospital immediately. Experts were consulted in various places around the world to diagnose her specific type of tumor, and to determine the best course of treatment for it.
We spent the next 5 months supporting Katie as she endured 5 rounds of toxic chemotherapy, as well as an 18-hour surgery to remove the tumor (and a kidney, adrenal gland, inferior vena cava and a lobe of her liver). It's a miracle that she survived this surgery, and she spent 6 weeks in the hospital, recovering from it. She then was allowed to go home to recuperate further, and began to take a pill-form of "maintenance" chemotherapy. By early summer, she was strong enough to go to the American Cancer Society's Camp Goodtimes West (on Vashon Island) for a week with her brother, David.
Sadly, a couple of weeks after camp, Katie began to suffer from severe pain. We took her to the clinic, and then to the hospital for a CT scan, & upon reviewing it, her doctor discovered another large tumor - but this one was inoperable. We took Katie home to begin hospice care.
The one bright spot during this time was that Katie's dream of being a bridesmaid came true. She was the maid of honor for her cousin Andrea's wedding to Mike Cunningham. Katie LOVED being their maid of honor. We treasure those memories.We (Katie's family) created this endowment in her honor, and we asked Katie what she wanted the funds to be used for. Her answer was that she wanted the endowment to support research to find a cure for solid tumors such as the one she had, which was adrenocortical carcinoma. She knew that the endowment was started before she passed away. The principal of the endowment is preserved, and the income is collected and used to fund research.
When Katie passed away, we asked people to donate to her endowment instead of sending flowers to us. The did this very generously, and many people have continued to support the endowment. It was up to nearly $80,000.00 last summer, before the stock market took a tumble. It is now near $66,000.00, and Dr. Julie Park (Katie's oncologist) is the one who advises us on where the income can best be used to carry out Katie's wishes.

If you would like to know more about the Katie Gerstenberger Endowment for Cancer Research, please leave a comment here. If you would like to donate to Seattle Children's Hospital in Katie's memory, please click HERE.
Subscribe to:
Posts (Atom)




